ZYPREXA 5 mg überzogene Tabletten 5 mg (überzogene Tablette)
- ATC
- N05AH03
- Reason
- Verzögerung in der Freigabe des Fertigproduktes
- Titular de la autorización de comercialización
- Cheplapharm Registration GmbH, Weiler Straße 5e, 79540 Lörrach, Federal Republic of Germany
- Affected packs
- 28 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-03-26, resupply 2026-06-16]
🚫 Parallel export ban active
What is this? ZYPREXA 5 mg are coated tablets that contain the active substance olanzapine. Olanzapine is a medicine used to treat mental health conditions.
What's happening? The supply of this medicine is currently delayed because the factory cannot make it right now. It should be back in stock by June 2026.
Does this affect me? If you take this medicine in Austria, you may not be able to get it until June 2026.
What should I do? Ask your pharmacist or doctor for advice before stopping or changing your medicine.
🤖 Este resumen en lenguaje sencillo se genera automáticamente a partir del aviso oficial de la agencia mediante IA. Es solo para fines informativos — no es un consejo médico. Para tomar decisiones sobre su salud, consulte siempre a un farmacéutico o médico y lea la fuente oficial vinculada a continuación.
🔬 Detalles médicos/técnicos Para profesionales
🚫 Parallel export ban active · ATC: N05AH03 · Reason: Verzögerung in der Freigabe des Fertigproduktes · Marketing authorisation holder: Cheplapharm Registration GmbH, Weiler Straße 5e, 79540 Lörrach, Federal Republic of Germany · Affected packs: 28 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-03-26, resupply 2026-06-16]
Toda la información de esta página proviene del aviso oficial de la agencia. Nosotros la traducimos y resumimos; no añadimos ni editamos datos.
